Iovance Biotherapeutics Inc (IOVA) Rapporto sugli Utili - Previsioni e Surprise Ratio

Pubblicita'

Storico dei ricavi trimestrali

IOVA rapporto: 37%

100%

IOVA supera 13 di 35 ultime stime

Data del prossimo reportFeb 26, 2025

Stimato per Q4 24:$-0.31

Cambiamenti implicati per il Q3 24:+10.71%

Cambiamenti implicati per il Q4 23:-31.11%

Periodo Bilanci	Data Riportata	EPS / Previsioni	Sorpresa
Q3 24	Nov 7, 2024	$-0.28 / $-0.31	$0.03 / 9.68%
Q2 24	Aug 8, 2024	$-0.34 / $-0.37	$0.03 / 8.11%
Q1 24	May 9, 2024	$-0.42 / $-0.45	$0.03 / 6.67%
Q4 23	Feb 28, 2024	$-0.45 / $-0.44	$-0.01 / -2.27%
Q3 23	Nov 7, 2023	$-0.46 / $-0.46	$0 / -
Q2 23	Aug 8, 2023	$-0.47 / $-0.81	$0.34 / 41.98%
Q1 23	May 9, 2023	$-0.5 / $-0.84	$0.34 / 40.48%
Q4 22	Feb 28, 2023	$-0.64 / $-0.64	$0 / -

Fornitori di Dati: Xignite Logo